Sign in
4

Changes in Ownership

Dare Bioscience, Inc. Filed Acc 0001209191-17-002984

Options or other derivatives

  • SVP, Chief Medical Officer acquired 210,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Senderowicz Adrian SVP, Chief Medical Officer 2017-01-05 Grant or award · Stock Option (right to buy) +60,000 60,000 D: show line 1 in the form
Senderowicz Adrian SVP, Chief Medical Officer 2017-01-05 Grant or award · Stock Option (right to buy) +150,000 150,000 D: show line 2 in the form
Loading xslF345X03/doc4.xml…